Kumar Virender, Encinosa William
Westat, Rockville, MD, USA.
Psychiatr Q. 2009 Sep;80(3):131-41. doi: 10.1007/s11126-009-9100-z. Epub 2009 Apr 22.
This study examined whether the relationship between HAART medication adherence and antidepressant treatment varied with HAART regimen complexity. The analysis included 1,192 respondents to the HIV Cost and Service Utilization Study (HCSUS) who were taking HAART. Self-reported past-week HAART adherence, antidepressant use, current mental health status, and an aggregate measure of regimen complexity were used in the analysis. Regression models with interactions between antidepressant treatment of mental health problems, poor emotional well-being or depressive symptoms, and medication complexity were estimated to assess differential associations with adherence. Irrespective of antidepressant treatment, poor mental health status was negatively associated with HAART medication adherence. However, only untreated higher depressive symptoms were strongly associated with maladherence to HAART medication (OR = 0.72 at P < 0.05). Medication complexity was strongly associated with maladherence to HAART medication (OR = 0.96 with P < 0.05) in the model including emotional well-being; and weakly associated with maladherence (OR = 0.97 and P < 0.07) in the model including depressive and/or anxiety symptoms. However, as HAART medication complexity increased, adherence was higher among individuals with poorer mental health but using antidepressants compared to those with better mental health (OR = 1.09 with P < 0.05 in the model including emotional well-being; OR = 1.09 and P < 0.05 in the model including depressive and/or anxiety symptoms), and compared to those with poorer mental health but not using antidepressants (OR = 1.09, P = 0.08 in the model including emotional well-being, and OR = 1.12, P < 0.05 in model including depressive and/or anxiety symptoms). In conclusion, while individuals with poorer mental health generally have poor HAART adherence, their adherence improved with the use of antidepressants as the HAART complexity increased.
本研究探讨了高效抗逆转录病毒治疗(HAART)药物依从性与抗抑郁治疗之间的关系是否会因HAART治疗方案的复杂性而有所不同。该分析纳入了1192名接受HAART治疗的艾滋病成本与服务利用研究(HCSUS)的受访者。分析中使用了自我报告的过去一周HAART依从性、抗抑郁药物使用情况、当前心理健康状况以及治疗方案复杂性的综合指标。估计了心理健康问题的抗抑郁治疗、情绪不佳或抑郁症状与药物治疗复杂性之间存在相互作用的回归模型,以评估与依从性的差异关联。无论抗抑郁治疗情况如何,心理健康状况不佳均与HAART药物依从性呈负相关。然而,只有未接受治疗的较高抑郁症状与HAART药物治疗依从性差密切相关(P < 0.05时,比值比为0.72)。在包括情绪健康的模型中,药物治疗复杂性与HAART药物治疗依从性差密切相关(P < 0.05时,比值比为0.96);在包括抑郁和/或焦虑症状的模型中,与依从性差的关联较弱(比值比为0.97,P < 0.07)。然而,随着HAART药物治疗复杂性的增加,心理健康较差但使用抗抑郁药物的个体的依从性高于心理健康较好的个体(在包括情绪健康的模型中,P < 0.05时,比值比为1.09;在包括抑郁和/或焦虑症状的模型中,比值比为1.09,P < 0.05),且高于心理健康较差但未使用抗抑郁药物的个体(在包括情绪健康的模型中,比值比为1.09,P = 0.08;在包括抑郁和/或焦虑症状的模型中,比值比为1.12,P < 0.05)。总之,虽然心理健康较差的个体通常HAART依从性较差,但随着HAART复杂性的增加,使用抗抑郁药物可改善他们的依从性。